Literature DB >> 30372891

Effects of statins on the chemoresistance-The antagonistic drug-drug interactions versus the anti-cancer effects.

Yasin Ahmadi1, Ramin Karimian2, Yunes Panahi3.   

Abstract

There has been growing interest in the potential anti-cancer activity of statins based on evidence of their anti-proliferative, pro-apoptotic, and radiosensitizing properties, but no studies have focused on the effects of statins on the chemoresistance. In spite of their direct cytostatic/cytotoxic effects on the cancer cells, statins via drug interactions may affect therapeutic effects of the chemotherapy agents and so cause chemoresistance in cancer cells. Here, we aim to present the molecular mechanisms underlying cytotoxic effects of statins on the cancer cells against those mechanisms by which statins may lead to chemoresistance, in order to clarify whether the positive effects of the co-treatment of statins on the efficiency of chemotherapeutic agents is due to the natural anti-cancer effects of statins or it is due to increasing the cellular concentrations of chemotherapy drugs in cancer cells.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; Chemoresistance; Chemotherapy; Prenylation; Statin

Mesh:

Substances:

Year:  2018        PMID: 30372891     DOI: 10.1016/j.biopha.2018.09.122

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes.

Authors:  Sadanori Okada; Takeshi Morimoto; Hisao Ogawa; Hirofumi Soejima; Chisa Matsumoto; Mio Sakuma; Masafumi Nakayama; Naofumi Doi; Hideaki Jinnouchi; Masako Waki; Izuru Masuda; Yoshihiko Saito
Journal:  J Gen Intern Med       Date:  2020-10-15       Impact factor: 5.128

Review 2.  Cancer Metabolism and the Evasion of Apoptotic Cell Death.

Authors:  Aditi Sharma; Lawrence H Boise; Mala Shanmugam
Journal:  Cancers (Basel)       Date:  2019-08-09       Impact factor: 6.639

3.  Time-dependent simvastatin administration enhances doxorubicin toxicity in neuroblastoma.

Authors:  Colin C Anderson; Meera Khatri; James R Roede
Journal:  Toxicol Rep       Date:  2020-04-22

Review 4.  Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential.

Authors:  Chang-Feng Deng; Neng Zhu; Tan-Jun Zhao; Hong-Fang Li; Jia Gu; Duan-Fang Liao; Li Qin
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244

Review 5.  Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review.

Authors:  M Kanmalar; Siti Fairus Abdul Sani; Nur Izzahtul Nabilla B Kamri; Nur Akmarina B M Said; Amirah Hajirah B A Jamil; S Kuppusamy; K S Mun; D A Bradley
Journal:  Cell Mol Biol Lett       Date:  2022-01-29       Impact factor: 5.787

6.  Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway.

Authors:  Danping Sun; Mingxiang Zhang; Meng Wei; Zhaoyang Wang; Wen Qiao; Peng Liu; Xin Zhong; Yize Liang; Yuanyuan Chen; Yadi Huang; Wenbin Yu
Journal:  Aging (Albany NY)       Date:  2022-05-04       Impact factor: 5.955

7.  Associations between statins and adverse events in secondary prevention of cardiovascular disease: Pairwise, network, and dose-response meta-analyses of 47 randomized controlled trials.

Authors:  Xinyi Wang; Jingen Li; Tongxin Wang; Zihao Zhang; Qiuyi Li; Dan Ma; Zhuo Chen; Jianqing Ju; Hao Xu; Keji Chen
Journal:  Front Cardiovasc Med       Date:  2022-08-25

Review 8.  MITOCHONDRIAL CHOLESTEROL AND CANCER.

Authors:  Carmen Garcia-Ruiz; Laura Conde de la Rosa; Vicent Ribas; Jose C Fernandez-Checa
Journal:  Semin Cancer Biol       Date:  2020-08-14       Impact factor: 17.012

9.  Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer.

Authors:  Gi-Hoon Nam; Minsu Kwon; Hanul Jung; Eunbyeol Ko; Seong A Kim; Yoonjeong Choi; Su Jeong Song; Seohyun Kim; Yeji Lee; Gi Beom Kim; Jihoon Han; Jiwan Woo; Yakdol Cho; Cherlhyun Jeong; Seung-Yoon Park; Thomas M Roberts; Yong Beom Cho; In-San Kim
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 12.469

Review 10.  Crosstalk between Statins and Cancer Prevention and Therapy: An Update.

Authors:  Beniamin Oskar Grabarek; Dariusz Boroń; Emilia Morawiec; Piotr Michalski; Veronica Palazzo-Michalska; Łukasz Pach; Barbara Dziuk; Magdalena Świder; Nikola Zmarzły
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.